In particular, mutation of IDH1 gene in gliomas has been shown to influence the methylation of a number of pro-malignant genes [3, 37], and is strongly associated with CD151 expression in our patient cohort (Fig. 1D). The gene discussed is IDH1; the disease is glioma.